[The effect of tanakan on central nervous system function in patients with the residual manifestations of stroke].
Kuznetsova
S M
SM
Glazovskaia
I I
II
Kuznetsov
V V
VV
D000368:Aged; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D002491:Central Nervous System Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D004341:Drug Evaluation; D004569:Electroencephalography / Q000187:drug effects; D005419:Flavonoids / Q000494:pharmacology / Q000627:therapeutic use*; D020441:Ginkgo biloba; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts; D013997:Time Factors; D000096983:Ginkgo Extract
D002491:Central Nervous System Agents; D005419:Flavonoids; D010936:Plant Extracts; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract
Vliianie tanakana na funktsional'noe sostoianie tsentral'noĭ nervnoĭ sistemy u bol'nykh s ostatochnymi iavleniiami insul'ta.